HDGF and hepatocellular carcinoma: Accordingly, a number of studies have focused on the significance of HDGF as a prognostic marker and have demonstrated its clinical value for oral cancer (9), esophageal cancer (10), gastrointestinal stromal tumors (11, 12), meningiomas (13), hepatocellular cancer (14), and non-small cell lung carcinoma (15).